Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Thürmann

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|February 25, 2016
[Influence of drugs on urological diseases]P A Thürmann
Cardiology|August 18, 1999
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophyP A Thürmann
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Gender-related differences in pharmacokinetics and pharmacodynamics]P A Thürmann
Journal of Cardiovascular Pharmacology|February 24, 1999
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophyP A Thürmann
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 7, 2001
[Pharmacotherapy of hypertension]P A Thürmann
Expert Opinion on Pharmacotherapy|March 16, 2001
Valsartan: a novel angiotensin type 1 receptor antagonistP A Thürmann
Drug Safety|December 12, 2001
Methods and systems to detect adverse drug reactions in hospitalsP A Thürmann
Zentralblatt Fur Chirurgie|February 19, 2008
[Chemotherapy in patients with colorectal carcinoma: applicability of data from clinical trials for the individual patient]P A Thürmann
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1997
Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implicationsP A Thürmann
Der Pathologe|December 13, 2005
[Adverse drugs reactions: diagnosis and assessment]P A Thürmann
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|February 25, 2016
[Influence of drugs on urological diseases]P A Thürmann
Cardiology|August 18, 1999
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophyP A Thürmann
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Gender-related differences in pharmacokinetics and pharmacodynamics]P A Thürmann
Journal of Cardiovascular Pharmacology|February 24, 1999
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophyP A Thürmann
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 7, 2001
[Pharmacotherapy of hypertension]P A Thürmann
Expert Opinion on Pharmacotherapy|March 16, 2001
Valsartan: a novel angiotensin type 1 receptor antagonistP A Thürmann
Drug Safety|December 12, 2001
Methods and systems to detect adverse drug reactions in hospitalsP A Thürmann
Zentralblatt Fur Chirurgie|February 19, 2008
[Chemotherapy in patients with colorectal carcinoma: applicability of data from clinical trials for the individual patient]P A Thürmann
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1997
Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implicationsP A Thürmann
Der Pathologe|December 13, 2005
[Adverse drugs reactions: diagnosis and assessment]P A Thürmann
Pageof 4